TX000045- Dose A, TX000045- Dose B — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-09 in 4mo
ESTIMATED |
READOUT
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart F
Phase 2 · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction |
TECX Tectonic Therapeutic, Inc. | TX000045- Dose A, TX000045- Dose B |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|